A new role for glucagon: from secondary hormone to key player
Open Access
- 15 July 2025
- journal article
- review article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 35 (12) , 104233
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world studyDiabetologia, 2023
- Dasiglucagon: an effective medicine for severe hypoglycemiaEuropean Journal of Clinical Pharmacology, 2021
- Novel Preparations of Glucagon for the Prevention and Treatment of HypoglycemiaCurrent Diabetes Reports, 2019
- No direct effect of SGLT2 activity on glucagon secretionDiabetologia, 2019
- Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated DiabetesDiabetes Therapy, 2016
- Diabetic ketoacidosis in type 2 diabetes mellitusPractical Diabetes, 2014
- Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjectsDiabetologia, 2007
- Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemiaDiabetologia, 2006
- Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDMDiabetologia, 1995
- Metabolic effects of intranasally administered glucagon: Comparison with intramuscular and intravenous injectionActa Diabetologica, 1985